/
DCF Valuation
Base-case fair value
$942.53
Intrinsic $1256.70 · 25% MOS
Current price: $457.09
Base-case summary
Our base-case DCF for Medpace Holdings, Inc. (MEDP) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 24.8% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $711M in trailing free cash flow, this produces an intrinsic value of $1256.70 per share. A 25% safety margin gives a fair value of $942.53, suggesting the stock is currently 106% undervalued against the $457.09 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$711M
Cash & equivalents
$653M
Total debt
$146M
Shares outstanding
29M